{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:23:19Z","timestamp":1790371399193,"version":"4.1.0"},"reference-count":70,"publisher":"Centers for Disease Control MMWR Office","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Surveill. Summ."],"DOI":"10.15585\/mmwr.ss6507a1","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T12:27:55Z","timestamp":1468499275000},"page":"1-19","source":"Crossref","is-referenced-by-count":229,"title":["<i>Neisseria gonorrhoeae<\/i>\n                    Antimicrobial Susceptibility Surveillance \u2014 The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014"],"prefix":"10.15585","volume":"65","author":[{"given":"Robert D.","family":"Kirkcaldy","sequence":"first","affiliation":[{"name":"Division of STD Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alesia","family":"Harvey","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Papp","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"del Rio","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health and Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun O.","family":"Soge","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"King K.","family":"Holmes","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Edward W.","family":"Hook","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kubin","sequence":"additional","affiliation":[{"name":"Texas Department of State Health Services, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Riedel","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MassachusettsJohns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Zenilman","sequence":"additional","affiliation":[{"name":"Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Pettus","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tremeka","family":"Sanders","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samera","family":"Sharpe","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Torrone","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2016,7,15]]},"reference":[{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R1","doi-asserted-by":"publisher","first-page":"ITC2","DOI":"10.7326\/0003-4819-158-3-201302050-01002","article-title":"Chlamydia and gonorrhea.","volume":"158","author":"Workowski","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/OLQ.0b013e31820b8eba","article-title":"High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers.","volume":"38","author":"Braunstein","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R3","unstructured":"CDC. National Notifiable Diseases Surveillance System (NNDSS). https:\/\/wwwn.cdc.gov\/nndss\/conditions\/gonorrhea\/"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R4","first-page":"1","article-title":"Reported incidence of notifiable diseases in the United States, 1968.","volume":"17","author":"CDC","year":"1968","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R5","first-page":"1","article-title":"Summary of notifiable diseases, United States 1994.","volume":"43","author":"Adams","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R6","first-page":"1","article-title":"Summary of notifiable diseases, United States, 1995.","volume":"44","author":"Adams","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R7","article-title":"Sexually transmitted disease surveillance 2014.","author":"CDC","year":"2015"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R8","doi-asserted-by":"crossref","DOI":"10.1542\/9781581108910-antimicrobial","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae.","author":"Kidd","year":"2014"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R9","article-title":"Issues in brief: the role of public health laboratories in STD testing","author":"Association of Public Health Laboratories STD Steering Committee"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM197601012940102","article-title":"National gonorrhea therapy monitoring study: in vitro antibiotic susceptibility and its correlation with treatment results.","volume":"294","author":"Jaffe","year":"1976","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/infdis\/144.2.191","article-title":"Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976\u20131980.","volume":"144","author":"Jaffe","year":"1981","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R12","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jama.1990.03450110059027","article-title":"National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project.","volume":"264","author":"Schwarcz","year":"1990","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/01.olq.0000431357.18959.30","article-title":"Gonococcal susceptibility to cephalosporins\u2014Hawaii, 2003 to 2011.","volume":"40","author":"Kidd","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/OLQ.0000000000000312","article-title":"Comparison of antimicrobial susceptibility of urogenital Neisseria gonorrhoeae isolates obtained from women and men.","volume":"42","author":"Kidd","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R15","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1128\/AAC.04476-14","article-title":"Comparison of antimicrobial susceptibilities of pharyngeal, rectal, and urethral Neisseria gonorrhoeae isolates among men who have sex with men.","volume":"59","author":"Kidd","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R16","article-title":"Performance standards for antimicrobial susceptibility testing. Twenty-fourth informational supplement. CLSI document M100-S24.","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R18","article-title":"Sexually transmitted diseases treatment guidelines, 2010.","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R19","first-page":"590","article-title":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R20","article-title":"CDC. Sexually transmitted diseases treatment guidelines, 2015.","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R21","first-page":"833","article-title":"Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.","volume":"49","author":"CDC","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R22","first-page":"1041","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001.","volume":"51","author":"CDC","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R23","first-page":"335","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men\u2014United States, 2003, and revised recommendations for gonorrhea treatment, 2004.","volume":"53","author":"CDC","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R24","first-page":"332","article-title":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.","volume":"56","author":"CDC","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R25","first-page":"1","article-title":"1989 sexually transmitted diseases treatment guidelines","volume":"38","author":"CDC","year":"1989","journal-title":"MMWR Suppl"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R26","first-page":"370","article-title":"Notice to readers: discontinuation of spectinomycin","volume":"55","author":"CDC","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R27","first-page":"29","article-title":"Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae\u2014United States, 1988\u20131991.","volume":"42","author":"Gorwitz","year":"1993","journal-title":"MMWR CDC Surveill Summ"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R28","unstructured":"National Strategy for Combating Antibiotic Resistant Bacteria. https:\/\/www.whitehouse.gov\/sites\/default\/files\/docs\/carb_national_strategy.pdf"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R29","first-page":"873","article-title":"Cephalosporin susceptibility among Neisseria gonorrhoeae isolates\u2014United States, 2000\u20132010.","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.7326\/0003-4819-158-5-201303050-00004","article-title":"Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005\u20132010.","volume":"158","author":"Kirkcaldy","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.OLQ.0000109514.91508.FC","article-title":"The emergence of Neisseria gonorrhoeae with decreased susceptibility to azithromycin in Kansas City, Missouri, 1999 to 2000.","volume":"31","author":"McLean","year":"2004","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R32","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.43.10.2468","article-title":"Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.","volume":"43","author":"Zarantonelli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0924-8579(03)00039-6","article-title":"Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae.","volume":"21","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/OLQ.0b013e3182685d2b","article-title":"Emergence of increased azithromycin resistance during unsuccessful treatment of Neisseria gonorrhoeae infection with azithromycin (Portland, OR, 2011).","volume":"39","author":"Soge","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S1473-3099(13)70693-5","article-title":"Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.","volume":"14","author":"Grad","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R36","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/01.olq.0000145846.45781.a4","article-title":"Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990\u20132000: role of foreign importation and increasing endemic spread.","volume":"31","author":"Iverson","year":"2004","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R37","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R38","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1128\/AAC.04337-14","article-title":"Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013.","volume":"59","author":"Kirkcaldy","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R39","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1056\/NEJMc1212055","article-title":"U.S. outpatient antibiotic prescribing, 2010.","volume":"368","author":"Hicks","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/cid\/cir443","article-title":"Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996\u20132003.","volume":"53","author":"Hicks","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R41","first-page":"1","article-title":"1998 guidelines for treatment of sexually transmitted diseases.","volume":"47","author":"CDC","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R42","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/jac\/dks449","article-title":"Combination therapy for gonorrhoea: in vitro synergy testing.","volume":"68","author":"Pereira","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R43","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/jac\/dkt540","article-title":"In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.","volume":"69","author":"Barbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R44","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw131","article-title":"High prevalence of Neisseria gonorrhoeae with high-level resistance to azithromycin in Hangzhou, China.","author":"Ni","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/OLQ.0000000000000279","article-title":"High prevalence of azithromycin-resistant Neisseria gonorrhoeae isolates with a multidrug resistance phenotype in Fukuoka, Japan.","volume":"42","author":"Tanaka","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3201\/eid2201.151247","article-title":"Decline in decreased cephalosporin susceptibility and increase in azithromycin resistance in Neisseria gonorrhoeae, Canada","volume":"22","author":"Martin","year":"2016;","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R47","doi-asserted-by":"publisher","first-page":"sextrans-2015-052312","DOI":"10.1136\/sextrans-2015-052312","article-title":"An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England.","author":"Chisholm","year":"2015","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3201\/eid1701.100397","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.","volume":"17","author":"Ohnishi","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R49","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.","volume":"67","author":"C\u00e1mara","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R50","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R51","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1473-3099(13)70143-9","article-title":"Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007\u20132011.","volume":"13","author":"Ison","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R52","unstructured":"Public Health England. GRASP 2013 report: the Gonococcal Resistance to Antimicrobials Surveillance Programme (England and Wales). October 2014. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/368477\/GRASP_Report_2013.pdf"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R53","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1473-3099(14)70015-5","article-title":"Decreased susceptibility to cephalosporins among gonococci [letter]?","volume":"14","author":"Lahra","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R54","first-page":"E137","article-title":"Australian Gonococcal Surveillance Programme annual report, 2013.","volume":"39","author":"Lahra","year":"2015","journal-title":"Commun Dis Intell Q Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R55","doi-asserted-by":"publisher","first-page":"iv28","DOI":"10.1136\/sextrans-2012-050904","article-title":"Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis.","volume":"89","author":"Bala","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R56","doi-asserted-by":"publisher","first-page":"342\u20138","DOI":"10.1186\/1471-2334-14-342","article-title":"Russian gonococcal antimicrobial susceptibility programme (RU-GASP)\u2014resistance in Neisseria gonorrhoeae during 2009\u20132012 and NG-MAST genotypes in 2011 and 2012.","volume":"14","author":"Kubanova","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R57","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/jac\/dku026","article-title":"Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006\u201312: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?","volume":"69","author":"Jeverica","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R58","article-title":"Gonococcal antimicrobial susceptibility surveillance in Europe, 2011","author":"European Centre for Disease Prevention and Control"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R59","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","article-title":"UK national guideline for the management of gonorrhoea in adults, 2011.","volume":"22","author":"Bignell","year":"2011","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R60","doi-asserted-by":"publisher","first-page":"321\u20138","DOI":"10.1186\/s12879-015-1013-x","article-title":"Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance.","volume":"15","author":"Cole","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R61","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/eva.12196","article-title":"The fitness costs of antibiotic resistance mutations.","volume":"8","author":"Melnyk","year":"2015","journal-title":"Evol Appl"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R62","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1128\/AAC.01295-13","article-title":"Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.","volume":"57","author":"Shimuta","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R63","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014.","volume":"63","author":"Papp","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R64","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1128\/AAC.01277-13","article-title":"The FDA reboot of antibiotic development.","volume":"57","author":"Shlaes","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R65","article-title":"1989 sexually transmitted diseases treatment guidelines","volume":"38","author":"CDC","year":"1989","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R66","article-title":"1993 sexually transmitted diseases treatment guidelines.","volume":"42","author":"CDC","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R67","article-title":"Sexually transmitted diseases treatment guidelines 2002.","volume":"51","author":"CDC","year":"2002;","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R68","article-title":"Sexually transmitted diseases treatment guidelines, 2006.","volume":"55","author":"Workowski","year":"2006;","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R69","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2105\/AJPH.2011.300283","article-title":"Changes in fluoroquinolone use for gonorrhea following publication of revised treatment guidelines.","volume":"102","author":"Dowell","year":"2012","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.ss6507a1-201607141201-R70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/OLQ.0000000000000217","article-title":"Gonorrhea treatment practices in the STD Surveillance Network, 2010\u20132012.","volume":"42","author":"Kerani","year":"2015","journal-title":"Sex Transm Dis"}],"container-title":["MMWR. Surveillance Summaries"],"original-title":[],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T23:10:24Z","timestamp":1656803424000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/65\/ss\/ss6507a1.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,15]]},"references-count":70,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,15]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.ss6507a1","relation":{},"ISSN":["1546-0738","1545-8636"],"issn-type":[{"value":"1546-0738","type":"print"},{"value":"1545-8636","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,7,15]]},"published":{"date-parts":[[2016,7,15]]}}}